No Data
XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2024
XORTX Therapeutics Stock Falls After Pricing $1.5M Capital Raise
Express News | XORTX Enters Securities Purchase Agreements With Institutional Investors For Purchase And Sale Of 810,810 Shares At $1.85/Common Share
XORTX Therapeutics Brief: Announcing Pricing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement
XORTX Announces Pricing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement
XORTX Initiates Precision Medicine Program
No Data
No Data
Stock_Drift OP Krystian 1983 : What’s down 30%?
Stock_Drift OP Krystian 1983 : Ask the market. I don’t control it, just report it.
Stock_Drift OP Krystian 1983 : Like a lot of them. $Maxeon Solar Technologies (MAXN.US)$ for example.
Krystian 1983 Stock_Drift OP : I Will try to report That
thanks you
Stock_Drift OP Krystian 1983 : Sorry. The market does what it does, even the best DD doesn’t always produce.
View more comments...